Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Etoposide + CHOP in Elderly NHL
NCT00060385Phase 3Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Mar 2003
- Primary completion
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etoposide in diffuse large B-cell lymphoma (DLBCL), peripheral T-cell lymphoma (PTCL), sponsored by European Organisation for Research and Treatment of Cancer. Started Mar 2003; status: terminated.
02
Drugs
etoposide
03
Conditions
diffuse large B-cell lymphoma (DLBCL)peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00060385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00060385.